Magnetic resonance imaging in patients with bone marrow disorders.

Magnetic resonance imaging (MRI) provides a non-invasive means to evaluate a large fraction of marrow in less than one hour. Marrow disorders produce non-specific changes in marrow signal intensities which primarily reflect changes in proportions of fat and cellular elements. The pattern of these signal changes narrows the differential diagnosis, and the combination of these features with the clinical context allows interpretations which are clinically useful in many ways. These include: 1) the diagnosis of avascular necrosis (and its distinction from other causes of joint pain), 2) detection of osteomyelitis, 3) differential diagnosis of hypoplastic disorders, 4) staging of lymphomas and myeloma, 5) selection of patients for autologous bone marrow transplant, 6) objective measures of marrow response to therapy, 7) detection of leukemic transformation, and 8) improved detection of marrow disease (primary or secondary) in patients with otherwise unexplained bone pain.

[1]  A. Al-Katib,et al.  Bone marrow necrosis in lymphoma studied by magnetic resonance imaging , 1992, American journal of hematology.

[2]  H. Hricak,et al.  Bone marrow imaging: magnetic resonance studies related to age and sex. , 1985, Radiology.

[3]  A. Shields,et al.  Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. , 1991, Blood.

[4]  N. Roberts,et al.  Detection of bone marrow abnormalities in patients with Hodgkin's disease by T1 mapping of MR images of lumbar vertebral bone marrow. , 1992, British Journal of Cancer.

[5]  W. Negendank,et al.  Periorbital necrobiotic xanthogranuloma and stage I multiple myeloma. Ultrastructure and response to pulsed dexamethasone documented by magnetic resonance imaging. , 1991, Journal of the American Academy of Dermatology.

[6]  S. Moore,et al.  Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. , 1990, Radiology.

[7]  A. Al-Katib,et al.  Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations. , 1990, Radiology.

[8]  V. Diehl,et al.  Malignant lymphoma: bone marrow imaging versus biopsy. , 1989, Radiology.

[9]  A. Rahmouni,et al.  Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. , 1990, Radiology.

[10]  D G Mitchell,et al.  Magnetic resonance imaging of bone marrow: diagnostic value in diffuse hematologic disorders. , 1990, Magnetic resonance quarterly.

[11]  J. J. Perry,et al.  Small cell lung cancer: staging with MR imaging. , 1990, Radiology.

[12]  A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastoma. , 1991, European journal of cancer.

[13]  W A Murphy,et al.  Bone marrow imaging. , 1988, Radiology.

[14]  A. Al-Katib,et al.  Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders. , 1991, Blood.

[15]  M. Amylon,et al.  Repopulation of marrow after transplantation: MR imaging with pathologic correlation. , 1990, Radiology.

[16]  R. Edwards,et al.  Quantitative magnetic resonance imaging in autologous bone marrow transplantation for Hodgkin's disease. , 1989, British Journal of Cancer.

[17]  A. Shields,et al.  Magnetic resonance imaging of bone marrow disorders. , 1986, Radiologic clinics of North America.

[18]  R Weissleder,et al.  Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. , 1991, Radiology.

[19]  V. Combaret,et al.  Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies. , 1989, British Journal of Cancer.

[20]  R. Reznek,et al.  In-vivo measurement of spin lattice relaxation time (T1) of bone marrow in healthy volunteers: the effects of age and sex. , 1988, The British journal of radiology.

[21]  M. A. Richards,et al.  Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma. , 1988, British Journal of Cancer.

[22]  H. Schaefer,et al.  Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. , 1985, Journal of clinical pathology.